跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
海尔思 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pentoxyverine Citrate and Ammonium Chloride Syrup
Approved
化学药品
Pentoxyverine Citrate and Ammonium Chloride Syrup
江西海尔思药业股份有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jul 2, 2020
Approval ID
7Leafa4iNtm
Company
江西海尔思药业股份有限公司
Type
化学药品
Approval Details
Approval Id
7Leafa4iNtm
Approval Number
国药准字H36021927
Generic Name
喷托维林氯化铵糖浆
Generic Name En
Pentoxyverine Citrate and Ammonium Chloride Syrup
Brand Name
海尔思
Drug Type
化学药品
Dosage Form
糖浆剂
Strength
枸橼酸喷托维林0.25%,氯化铵3%
Reg Date
2020-07-02
Company Name
江西海尔思药业股份有限公司
Production Company Name
江西海尔思药业股份有限公司
Production Company Address
江西省宜春市袁州医药工业园
Company Detail Path
/organization/jiang-xi-hai-er-si-yao-ye-gu-fen-you-xian-gong-si
Production Company Detail Path
/organization/jiang-xi-hai-er-si-yao-ye-gu-fen-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 2, 2020
Approval ID
7Leafa4iNtm
Type
化学药品
Back to NMPA Approvals